logo
Select company
Select metric
-270.18%EBIT Margin
VS
Market
9
Sector
31
Industry
55
History
67
$ 1.01Close
$ 0.85 - $ 4.86 52-Week Range
Ticker Information

Ticker

MRKR

Company Name

MARKER THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MARKER THERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MRKR - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -14.56M-270.18%$ 5.39M
3/31/2025$ -12.73M-223.57%$ 5.7M
12/31/2024$ -10.68M-162.06%$ 6.59M
9/30/2024$ -9.69M-179.64%$ 5.4M
6/30/2024$ -10.37M-278.12%$ 3.73M
3/31/2024$ -5.66M-170.39%$ 3.32M
12/31/2023$ -8.23M-248.65%$ 3.31M
9/30/2023$ -9.29M-102.5%$ 9.06M
6/30/2023$ -13.23M-103.7%$ 12.76M
3/31/2023$ -24.99M-195.47%$ 12.78M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MARKER THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at -3717.47%.
  • Over the past 5 years, MARKER THERAPEUTICS INC's average EBIT % has been -1444.04%.
  • The median EBIT % for MARKER THERAPEUTICS INC during this period was -274.15%
  • MARKER THERAPEUTICS INC reached its highest EBIT % over the past 5 years at -102.5%.
  • The lowest EBIT % recorded by MARKER THERAPEUTICS INC in the same timeframe -6641.15%

MARKER THERAPEUTICS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
LPCN : LIPOCINE INC -107.1%BOLT : BOLT BIOTHERAPEUTICS INC -1217.01%XAIR : BEYOND AIR INC -826.24%TRAW : TRAWS PHARMA INC 3028.25%INM : INMED PHARMACEUTICALS INC -157.62%LGVN : LONGEVERON INC -894.31%LEXX : LEXARIA BIOSCIENCE CORP -1849.39%NBY : NOVABAY PHARMACEUTICALS INC 69.98%NRXS : NEURAXIS INC -220.34%IBIO : IBIO INC -4541.25%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for MARKER THERAPEUTICS INC is calculated as follows: EBIT [ $ -25.28M ] / Revenues [ $ 679.98K ]
(=) EBIT % [ -3717.47% ]

MRKR - EBIT Margin, Last 5 years

-6641.15%

Minimum

Mar 31, 2021

-102.5%

Maximum

Sep 30, 2023

-1444.04%

Average

-274.15%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%